640 related articles for article (PubMed ID: 31867675)
1. Cardiometabolic health in offspring of women with PCOS compared to healthy controls: a systematic review and individual participant data meta-analysis.
Gunning MN; Sir Petermann T; Crisosto N; van Rijn BB; de Wilde MA; Christ JP; Uiterwaal CSPM; de Jager W; Eijkemans MJC; Kunselman AR; Legro RS; Fauser BCJM
Hum Reprod Update; 2020 Jan; 26(1):103-117. PubMed ID: 31867675
[TBL] [Abstract][Full Text] [Related]
2. [Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome].
Roa Barrios M; Arata-Bellabarba G; Valeri L; Velázquez-Maldonado E
Endocrinol Nutr; 2009 Feb; 56(2):59-65. PubMed ID: 19627713
[TBL] [Abstract][Full Text] [Related]
3. Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis.
Wekker V; van Dammen L; Koning A; Heida KY; Painter RC; Limpens J; Laven JSE; Roeters van Lennep JE; Roseboom TJ; Hoek A
Hum Reprod Update; 2020 Nov; 26(6):942-960. PubMed ID: 32995872
[TBL] [Abstract][Full Text] [Related]
4. A visceral adiposity index-related dietary pattern and the cardiometabolic profiles in women with polycystic ovary syndrome.
Ehsani B; Moslehi N; Mirmiran P; Ramezani Tehrani F; Tahmasebinejad Z; Azizi F
Clin Nutr; 2016 Oct; 35(5):1181-7. PubMed ID: 26699405
[TBL] [Abstract][Full Text] [Related]
5. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables.
Holte J; Bergh T; Berne C; Lithell H
Clin Endocrinol (Oxf); 1994 Oct; 41(4):463-71. PubMed ID: 7955457
[TBL] [Abstract][Full Text] [Related]
6. Metabolic effect of obesity on polycystic ovary syndrome in adolescents: a meta-analysis.
Li L; Feng Q; Ye M; He Y; Yao A; Shi K
J Obstet Gynaecol; 2017 Nov; 37(8):1036-1047. PubMed ID: 28657375
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the cardiometabolic profiles of adolescents conceived through ART with those of a non-ART cohort.
Wijs LA; Doherty DA; Keelan JA; Burton P; Yovich JL; Beilin L; Mori TA; Huang RC; Adams LA; Olynyk JK; Ayonrinde OT; Penova-Veselinovic B; Hart RJ
Hum Reprod; 2022 Jul; 37(8):1880-1895. PubMed ID: 35640037
[TBL] [Abstract][Full Text] [Related]
8. Disparities in cardio metabolic risk between Black and White women with polycystic ovary syndrome: a systematic review and meta-analysis.
Kazemi M; Kim JY; Parry SA; Azziz R; Lujan ME
Am J Obstet Gynecol; 2021 May; 224(5):428-444.e8. PubMed ID: 33316275
[TBL] [Abstract][Full Text] [Related]
9. Is serum leptin level regulated by thyroid functions, lipid metabolism and insulin resistance in polycystic ovary syndrome?
Erel CT; Senturk LM; Kaleli S; Gezer A; Baysal B; Tasan E
Gynecol Endocrinol; 2003 Jun; 17(3):223-9. PubMed ID: 12857430
[TBL] [Abstract][Full Text] [Related]
10. Associations of preconception Body Mass Index in women with PCOS and BMI and blood pressure of their offspring.
Gunning MN; van Rijn BB; Bekker MN; de Wilde MA; Eijkemans MJC; Fauser BCJM
Gynecol Endocrinol; 2019 Aug; 35(8):673-678. PubMed ID: 31030581
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Profiles in Reproductive-Age Women with Polycystic Ovary Syndrome: A Large Canadian Cohort.
Kazemi M; Pierson RA; Lujan ME; Chilibeck PD; McBreairty LE; Gordon JJ; Serrao SB; Zello GA; Chizen DR
J Obstet Gynaecol Can; 2019 Oct; 41(10):1453-1460. PubMed ID: 30712903
[TBL] [Abstract][Full Text] [Related]
12. Altered composition of high density lipoproteins in women with the polycystic ovary syndrome.
Rajkhowa M; Neary RH; Kumpatla P; Game FL; Jones PW; Obhrai MS; Clayton RN
J Clin Endocrinol Metab; 1997 Oct; 82(10):3389-94. PubMed ID: 9329374
[TBL] [Abstract][Full Text] [Related]
13. Triglycerides to High-Density Lipoprotein Cholesterol Ratio Can Predict Impaired Glucose Tolerance in Young Women with Polycystic Ovary Syndrome.
Song do K; Lee H; Sung YA; Oh JY
Yonsei Med J; 2016 Nov; 57(6):1404-11. PubMed ID: 27593868
[TBL] [Abstract][Full Text] [Related]
14. Using metabolic markers to identify insulin resistance in premenopausal women with and without polycystic ovary syndrome.
Blum MR; Popat RA; Nagy A; Cataldo NA; McLaughlin TL
J Endocrinol Invest; 2021 Oct; 44(10):2123-2130. PubMed ID: 33687700
[TBL] [Abstract][Full Text] [Related]
15. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.
Daan NM; Jaspers L; Koster MP; Broekmans FJ; de Rijke YB; Franco OH; Laven JS; Kavousi M; Fauser BC
Hum Reprod; 2015 Oct; 30(10):2376-86. PubMed ID: 26269538
[TBL] [Abstract][Full Text] [Related]
16. Serum pigment epithelium-derived factor is elevated in women with polycystic ovary syndrome and correlates with insulin resistance.
Yang S; Li Q; Zhong L; Song Y; Tian B; Cheng Q; Qing H; Xia W; Luo M; Mei M
J Clin Endocrinol Metab; 2011 Mar; 96(3):831-6. PubMed ID: 21209034
[TBL] [Abstract][Full Text] [Related]
17. Women with polycystic ovary syndrome demonstrate worsening markers of cardiovascular risk over the short-term despite declining hyperandrogenaemia: Results of a longitudinal study with community controls.
Huddleston HG; Quinn MM; Kao CN; Lenhart N; Rosen MP; Cedars MI
Clin Endocrinol (Oxf); 2017 Dec; 87(6):775-782. PubMed ID: 29044581
[TBL] [Abstract][Full Text] [Related]
18. Endocrine and cardiometabolic cord blood characteristics of offspring born to mothers with and without polycystic ovary syndrome.
Daan NM; Koster MP; Steegers-Theunissen RP; Eijkemans MJ; Fauser BC
Fertil Steril; 2017 Jan; 107(1):261-268.e3. PubMed ID: 28228318
[TBL] [Abstract][Full Text] [Related]
19. PCOS during the menopausal transition and after menopause: a systematic review and meta-analysis.
Millán-de-Meer M; Luque-Ramírez M; Nattero-Chávez L; Escobar-Morreale HF
Hum Reprod Update; 2023 Nov; 29(6):741-772. PubMed ID: 37353908
[TBL] [Abstract][Full Text] [Related]
20. Raised plasminogen activator inhibitor-1 (PAI-1) is not an independent risk factor in the polycystic ovary syndrome (PCOS).
Atiomo WU; Fox R; Condon JE; Shaw S; Friend J; Prentice AG; Wilkin TJ
Clin Endocrinol (Oxf); 2000 Apr; 52(4):487-92. PubMed ID: 10762292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
